ArticleVirus genes2009
One-step column purification of herpes simplex virus 1 helicase-primase subcomplex using C-terminally his-tagged UL5 subunit.
Article in Virus genes, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A protocol for purification of the two-subunit complex of herpes simplex virus type 1 (HSV-1) helicase-primase by metal affinity chromatography is presented. In order to bind the enzyme complex consisting of UL5 and UL52 gene functions to the affinity column, the C-terminus of the UL5 gene of HSV-1 strain ANG was fused in-frame with a sequence encoding six histidines, resulting in a His6-tagged DNA helicase (UL5his) when expressed via recombinant baculovirus. In addition, hybridoma cell lines producing anti-UL5 IgG were generated for screening of DNA helicase expression. Initial purification trials revealed that the presence of low concentrations of imidazole in the wash buffers interfered with the binding of the helicase-primase subunit complex to the metal affinity resin. Alternative means, such as high salt, altered pH, and substitution of imidazole by histidine tetrapeptide (His4), were tested. From those, the addition of His4 in combination with an acidic pH turned out to be very efficient for the removal of protein contaminants from a Ni2+-NTA (nitrilotriacidic acid) affinity resin. By applying only one column step, the present protocol yields a helicase-primase preparation, which is suitable for inhibitor screening and further functional studies. The final preparation is free of interfering enzyme activities, and exerts each of the enzymatic functions described for a two subunit complex, i.e., DNA-dependent ATPase, DNA primase, and DNA helicase activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.